CARLSBAD, Calif.--(BUSINESS WIRE)--
GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of
automated, multiplex molecular diagnostic testing systems, will present
at the Bank of America Merrill Lynch 2017 Health Care Conference in Las
Vegas, Nevada, on Tuesday, May 16, 2017. The presentation will be
delivered by Hany
Massarany, President and Chief Executive Officer, and is scheduled
to begin at 10:00 a.m. (PT). The presentation will be made available at http://ir.genmarkdx.com/.
ABOUT GENMARK DIAGNOSTICS
Diagnostics (NASDAQ: GNMK) is a leading provider of multiplex
molecular diagnostic solutions designed to enhance patient care, improve
key quality metrics, and reduce the total cost-of-care. Utilizing
GenMark's proprietary eSensor® detection technology, GenMark's eSensor
XT-8® and ePlex® systems are designed to support a broad range of
molecular diagnostic tests with a compact, easy-to-use workstation and
self-contained, disposable test cartridges. GenMark's ePlex®: The True
Sample-to-Answer Solution™ is designed to optimize laboratory efficiency
and address a broad range of infectious disease testing needs, including
respiratory, bloodstream, and gastrointestinal infections. For more
information, visit www.genmarkdx.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170503006763/en/
GenMark Diagnostics, Inc.
Source: GenMark Diagnostics, Inc.
News Provided by Acquire Media